EPISODE · Apr 25, 2026 · 1 MIN
Foundayo's Slow Start Dents Lilly's Stock
from The Daily News Now! Business
Eli Lillys new weight loss pill, Foundayo, underperforms in early sales, with only 3,707 prescriptions in its second week, far behind Novo Nordisks Wegovy. Investors express concern, but Lilly maintains optimism, emphasizing the importance of tracking long-term trends. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6c4cc3d67a060811
NOW PLAYING
Foundayo's Slow Start Dents Lilly's Stock
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m